CohBar, Inc. Profile Avatar - Palmy Investing

CohBar, Inc.

CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatiti…

Biotechnology
US, Menlo Park [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of CWBR's Analysis
CIK: 1522602 CUSIP: 19249J109 ISIN: US19249J3077 LEI: - UEI: -
Secondary Listings
CWBR has no secondary listings inside our databases.